María Dolores
Lozano Escario
Consultora Médica
Jackeline
Agorreta Arrazubi
Publicacións nas que colabora con Jackeline Agorreta Arrazubi (12)
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
2015
2013
-
Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer
Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393
2012
-
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung
Journal of Clinical Oncology, Vol. 30, Núm. 10, pp. 1129-1136
2011
-
Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance
Clinical Cancer Research, Vol. 17, Núm. 12, pp. 4155-4166
2010
-
Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
BMC Genomics, Vol. 11, Núm. 1
-
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Molecular Cancer, Vol. 9
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486
2008
2006
-
Molecular profiling of computed tomography screen-detected lung nodules shows multiple malignant features
Cancer Epidemiology Biomarkers and Prevention, Vol. 15, Núm. 2, pp. 373-380